CHEK2 Emerges as a Promising Target to Enhance Immunotherapy in Solid Tumors
In recent years, the landscape of cancer treatment has been dramatically transformed by the advent of immune checkpoint inhibitors (ICIs), ...
In recent years, the landscape of cancer treatment has been dramatically transformed by the advent of immune checkpoint inhibitors (ICIs), ...
Professor Marco Durante, a leading figure in the field of biophysics and heavy-ion therapy, has been honored with the European ...
In a groundbreaking development that may revolutionize cancer treatment, a team of researchers at Southern Medical University has engineered a ...
In a groundbreaking advancement presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, researchers from Dana-Farber Cancer ...
A groundbreaking clinical trial presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting heralds a transformative shift ...
A venerable cornerstone of cancer immunotherapy, the Bacillus Calmette-Guérin (BCG) vaccine, long used to combat tuberculosis and as a first-line ...
In a groundbreaking advance that promises to revolutionize cancer treatment and pharmaceutical manufacturing, researchers from the University of Copenhagen have ...
In the evolving battleground of oncology, few molecular targets have captured as much attention and complexity as the MYC protein. ...
In a groundbreaking study published in Science, researchers led by Dr. Kim V. Narry, the director of the Center for ...
Scientists at Scripps Research have made a breakthrough in the field of protease engineering that could potentially revolutionize treatment options ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine